These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 30821827)

  • 21. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.
    Gareen IF; Duan F; Greco EM; Snyder BS; Boiselle PM; Park ER; Fryback D; Gatsonis C
    Cancer; 2014 Nov; 120(21):3401-9. PubMed ID: 25065710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Different Approaches to Leveraging Historical Smoking Exposure Data to Better Select Lung Cancer Screening Candidates: A Retrospective Validation Study.
    Kats DJ; Adie Y; Tlimat A; Greco PJ; Kaelber DC; Tarabichi Y
    Nicotine Tob Res; 2021 Aug; 23(8):1334-1340. PubMed ID: 32974635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor.
    Wilson DO; Weissfeld J
    Lung Cancer; 2015 Jul; 89(1):31-7. PubMed ID: 25863905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
    Pinsky P; Gierada DS
    Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.
    Pinsky PF; Bellinger CR; Miller DP
    J Med Screen; 2018 Jun; 25(2):110-112. PubMed ID: 28929865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
    Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
    PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
    Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
    Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the accuracy of the PLCO
    Jantzen R; Ezer N; Camilleri-Broët S; Tammemägi MC; Broët P
    CMAJ Open; 2023; 11(2):E314-E322. PubMed ID: 37041013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks.
    Robbins HA; Cheung LC; Chaturvedi AK; Baldwin DR; Berg CD; Katki HA
    J Thorac Oncol; 2022 Feb; 17(2):252-263. PubMed ID: 34648946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
    Robertson SE; Joyce NR; Steingrimsson JA; Stuart EA; Aberle DR; Gatsonis CA; Dahabreh IJ
    JAMA Netw Open; 2024 Jan; 7(1):e2346295. PubMed ID: 38289605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
    Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
    BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.
    Gierada DS; Pinsky PF; Duan F; Garg K; Hart EM; Kazerooni EA; Nath H; Watts JR; Aberle DR
    Eur Radiol; 2017 Aug; 27(8):3249-3256. PubMed ID: 28050695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
    Hendrick RE; Smith RA
    Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
    Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of initial low-dose computed tomographic screening for lung cancer.
    ; Church TR; Black WC; Aberle DR; Berg CD; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gierada DS; Jones GC; Mahon I; Marcus PM; Sicks JD; Jain A; Baum S
    N Engl J Med; 2013 May; 368(21):1980-91. PubMed ID: 23697514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.